A rapid test for the qualitative detection of Influenza A & B Antigens in nasal swab specimens.

The Control Swabs are intended for use only with the Alere Influenza A & B Test.

Control Swabs intended for use only with the ID NOW Influenza A & B product.

A rapid, automated, molecular test for the qualitative detection of influenza A and B viral nucleic acid in respiratory specimens.

A rapid test for the qualitative detection of Influenza A & B antigens with NP swab and nasal swab specimens.

A rapid test for the qualitative detection of Influenza A & B antigens with NP swab and nasal swab specimens

Control Swabs ntended for use only with BinaxNOW™ Influenza A & B 2 Card product.

Control Swabs intended for use only with Alere BinaxNOW® Influenza A & B Card 2 product.

Kit Flu A+B 30 Test Hospital Veritor

Kit Flu A+B 30 Test Physician Veritor

BD Veritor™ System CLIA-Waived Combo Pack Contains: 2xBD Veritor ™ System for Rapid Detection of Flu A+B, CLIA-Wavied Kits (Cat. No. 256045) 1xBD Veritor ™ System Reader (Cat. No. 256055)

ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test Kit, 25 tests

Nasopharyngeal Wash/Aspirate Kit for use with ImmunoCard STAT! FLU A&B. ImmunoCard STAT! Flu A&B is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly form nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.Moderate Complexity when used with Nasal Wash/Aspirate Samples.

ImmunoCard STAT! Flu A&B is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly form nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.Moderate Complexity when used with Nasal Wash/Aspirate Samples. CLIA Waived when used with Nasal and Nasopharyngeal Swabs.

The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. The Nano-Check™ Influenza+COVID-19 Dual Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. This product has not been cleared or approved.

An in vitro diagnostic test for the detection of influenza A and influenza B viral nucleoprotein antigens from nasopharyngeal secretion specimens in symptomatic patients.

Status™ COVID-19/Flu A&B Antigen test kit, 25 tests

Xpect Flu A&B KT/20TST

OSOM Ultra Flu A&B 25T Kit

OSOM Ultra Flu Aspirate 25T Kit

Acucy Influenza A&B Test Kit